|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ma C, Liu Y, Zheng J, Fang W, You J, Wang
J, Cui X and Wu B: Identification of tumor metastasisrelated gene
TMSG-1 by mRNA differential display. Sci China C Life Sci.
45:553–560. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yu W, Wang L, Wang Y, Xu X, Zou P, Gong M,
Zheng J, You J, Wang H, Mei F and Pei F: A novel tumor metastasis
suppressor gene LASS2/TMSG1 interacts with vacuolar ATPase through
its homeodomain. J Cell Biochem. 114:570–583. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu XY, You JF, Pei F and Zhang B:
Silencing of tumor metastasis suppressor gene 1 promotes invasion
of prostate cancer cell in vitro and its molecular mechanisms.
Beijing Da Xue Xue Bao. 43:814–819. 2011.(In Chinese). PubMed/NCBI
|
|
6
|
Xu X, You J and Pei F: Silencing of a
novel tumor metastasis suppressor gene LASS2/TMSG1 promotes
invasion of prostate cancer cell in vitro through increase of
vacuolar ATPase activity. J Cell Biochem. 113:2356–2363. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang N, Jin J, Deng Y, Ke RH, Shen QJ, Fan
SH and Qin WX: LASS2 interacts with V-ATPase and inhibits cell
growth of hepatocellular carcinoma. Sheng Li Xue Bao. 62:196–202.
2010.(In Chinese). PubMed/NCBI
|
|
8
|
Fan S, Niu Y, Tan N, Wu Z, Wang Y, You H,
Ke R, Song J, Shen Q, Wang W, et al: LASS2 enhances
chemosensitivity of breast cancer by counteracting acidic tumor
microenvironment through inhibiting activity of V-ATPase proton
pump. Oncogene. 32:1682–1690. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schiffmann S, Sandner J, Birod K, Wobst I,
Angioni C, Ruckhäberle E, Kaufmann M, Ackermann H, Lötsch J,
Schmidt H, et al: Ceramide synthases and ceramide levels are
increased in breast cancer tissue. Carcinogenesis. 30:745–752.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang H, Wang J, Zuo Y, Ding M, Yan R, Yang
D and Ke C: Expression and prognostic significance of a new tumor
metastasis suppressor gene LASS2 in human bladder carcinoma. Med
Oncol. 29:1921–1927. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang D, Wang H, Wang J, Zhang C and Xu H:
Establishment of a fluorescent implantation metastasis model of
bladder cancer and real-time microscopic detection in nude mice.
Asian Pacific J Cancer Prev. 12:393–396. 2011.
|
|
12
|
Girnita A, All-Ericsson C, Economou MA,
Aström K, Axelson M, Seregard S, Larsson O and Girnita L: The
insulin-like growth factor-I receptor inhibitor picropodophyllin
causes tumor regression and attenuates mechanisms involved in
invasion of uveal melanoma cells. Clin Cancer Res. 12:1383–1391.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao Q, Wang H, Yang M, Yang D, Zuo Y and
Wang J: Expression of a tumor-associated gene, LASS2, in the human
bladder carcinoma cell lines BIU-87, T24, EJ and EJ-M3. Exp Ther
Med. 5:942–946. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cumashi A, Tinari N, Rossi C, Lattanzio R,
Natoli C, Piantelli M and Iacobelli S: Sunitinib malate (SU-11248)
alone or in combination with low-dose docetaxel inhibits the growth
of DU-145 prostate cancer xenografts. Cancer Lett. 270:229–233.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang CJ, Zhou ZG, Holmqvist A, Zhang H, Li
Y, Adell G and Sun XF: Survivin expression quantified by image
Pro-Plus compared with visual assessment. Appl Immunohistochem Mol
Morphol. 17:530–535. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Su J, You JF, Wang JL, Cui XL, Fang WG and
Zheng J: Overexpression of human tumor metastasis-related gene
TMSG-1 suppresses cell proliferation and invasion of a highly
metastatic prostate cancer cell line PC-3M-1E8 in vitro. Zhonghua
Zhong Liu Za Zhi. 30:404–407. 2008.(In Chinese). PubMed/NCBI
|
|
18
|
Mei F, You J, Liu B, Zhang M, Liu J, Zhang
B and Pei F: LASS2/TMSG1 inhibits growth and invasion of breast
cancer cell in vitro through regulation of vacuolar ATPase
activity. Tumour Biol. 36:2831–2844. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu XY, Pei F and You JF: TMSG-1 and its
roles in tumor biology. Chin J Cancer. 29:697–702. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu X, Liu B, Zou P, Zhang Y, You J and Pei
F: Silencing of LASS2/TMSG1 enhances invasion and metastasis
capacity of prostate cancer cell. J Cell Biochem. 115:731–743.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sennoune SR, Luo D and Martinez-Zaguilán
R: Plasmalemmal vacuolar-type H+-ATPase in cancer biology. Cell
Biochem Biophys. 40:185–206. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fais S, De Milito A, You H and Qin W:
Targeting vacuolar H+-ATPases as a new strategy against cancer.
Cancer Res. 67:10627–10630. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rossi MJ, Sundararaj K, Koybasi S,
Phillips MS, Szulc ZM, Bielawska A, Day TA, Obeid LM, Hannun YA and
Ogretmen B: Inhibition of growth and telomerase activity by novel
cationic ceramide analogs with high solubility in human head and
neck squamous cell carcinoma cells. Otolaryngol Head Neck Surg.
132:55–62. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Su J, Yu W, Gong M, You J, Liu J and Zheng
J: Overexpression of a novel tumor metastasis suppressor gene
TMSG1/LASS2 induces apoptosis via a caspase-dependent mitochondrial
pathway. J Cell Biochem. 116:1310–1317. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu X, Chen Y, Zeng T, Chen L, Shao Q and
Qin W: Knockout of the HCC suppressor gene Lass2 downregulates the
expression level of miR-694. Oncol Rep. 32:2696–2702. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang H, Wang J, Zuo Y, Ding M, Yan R, Yang
D and Ke C: Expression and prognostic significance of a new tumor
metastasis suppressor gene LASS2 in human bladder carcinoma. Med
Oncol. 29:1921–1927. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang H, Zhang W, Zuo Y, Ding M, Ke C, Yan
R, Zhan H, Liu J and Wang J: miR-9 promotes cell proliferation and
inhibits apoptosis by targeting LASS2 in bladder cancer. Tumour
Biol. 36:9631–9640. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang H, Zuo Y, Ding M, Ke C, Yan R, Zhan
H, Liu J, Wang W, Li N and Wang J: LASS2 inhibits growth and
invasion of bladder cancer by regulating ATPase activity. Oncol
Lett. 13:661–668. 2017.PubMed/NCBI
|
|
29
|
Chen L, Lu X, Zeng T, Chen Y, Chen Q, Wu
W, Yan X, Cai H, Zhang Z, Shao Q and Qin W: Enhancement of
DEN-induced liver tumourigenesis in hepatocyte-specific
Lass2-knockout mice coincident with upregulation of the
TGF-β1-Smad4-PAI-1 axis. Oncol Rep. 31:885–893. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu X, You J and Pei F: Silencing of a
novel tumor metastasis suppressor gene LASS2/TMSG1 promotes
invasion of prostate cancer cell in vitro through increase of
vacuolar ATPase activity. J Cell Biochem. 113:2356–2363. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guo F, Tian J, Cui M, Fang M and Yang L:
Downregulation of matrix metalloproteinase 9 by small interfering
RNA inhibits the tumor growth of ovarian epithelial carcinoma in
vitro and in vivo. Mol Med Rep. 12:753–759. 2015. View Article : Google Scholar : PubMed/NCBI
|
